Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation Fellows 2025

State-of-the-Art in NSTE-ACS: Management Strategies and Guidelines Update

Presenter: Binita Shah

May 16, 2025

Presentation Fellows 2024

High-Bleeding Risk Patient Who Needs Surgery after PCI

Presenter: Sanjum S. Sethi

April 13, 2024

Presentation Fellows 2024

Elective PCI Case: Prior CTA With High Calcium Score and MVD

Presenter: Darshan Doshi

April 13, 2024

Presentation Fellows 2024

ACS PCI Case: Loading, Timing, Transitions, and Other Issues

Presenter: Binita Shah

April 13, 2024

Presentation Fellows 2024

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Binita Shah

April 12, 2024

Presentation Fellows 2024

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Presenter: David J. Cohen

April 12, 2024

Presentation Fellows 2023

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Robert Yeh

May 11, 2023

Presentation Fellows 2023

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Presenter: Nicholas Lembo

May 11, 2023

Presentation Fellows 2022

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Robert Yeh

May 06, 2022

Presentation Fellows 2017

The History of Reperfusion Therapies in STEMI: How Far Weve Come

Presenter: Ajay J. Kirtane, Gregg W. Stone

April 07, 2017

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

Presentation Fellows 2012

Oral Antithrombin and Xa Inhibitors for ACS and PCI

Presenter: Michael Ezekowitz

April 22, 2012

Presentation Fellows 2012

Oral Antiplatelet Agents in PCI and ACS

Presenter: Roxana Mehran

April 22, 2012

Presentation Fellows 2012

Bivalirudin in ACS and PCI

Presenter: Gregg Stone

April 22, 2012

Advertisement

State-of-the-Art in NSTE-ACS: Management Strategies and Guidelines Update

High-Bleeding Risk Patient Who Needs Surgery after PCI

Elective PCI Case: Prior CTA With High Calcium Score and MVD

ACS PCI Case: Loading, Timing, Transitions, and Other Issues

State-of-the-Art in NSTE-ACS: Management Strategies

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

State-of-the-Art in NSTE-ACS: Management Strategies

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

State-of-the-Art in NSTE-ACS: Management Strategies

The History of Reperfusion Therapies in STEMI: How Far Weve Come

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Oral Antithrombin and Xa Inhibitors for ACS and PCI

Oral Antiplatelet Agents in PCI and ACS

Bivalirudin in ACS and PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content